Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer

Background: High tumor mutational burden (TMB-H) has been reported as a predictive marker to immunotherapy or prognostic marker in various tumor types. However, there has been little study of the role of TMB-H in advanced biliary tract cancer (BTC). Methods: We analyzed 119 advanced BTC patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hongsik, Kim, Hana, Kim, Ryul, Jo, Hyunji, Kim, Hye Ryeon, Hong, Joohyun, Park, Joon Oh, Park, Young Suk, Kim, Seung Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646759/
https://www.ncbi.nlm.nih.gov/pubmed/34855561
http://dx.doi.org/10.1177/15330338211062324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646759/
https://www.ncbi.nlm.nih.gov/pubmed/34855561
http://dx.doi.org/10.1177/15330338211062324

Ejemplares similares